Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Invivoscribe
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide
Today 0:30 EST
From
Invivoscribe
Via
Business Wire
LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials
June 18, 2025
From
Invivoscribe
Via
Business Wire
Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay
April 22, 2025
From
Invivoscribe
Via
Business Wire
Invivoscribe Announces Registration of the LeukoStrat® CDx FLT3 Mutation Assay in the United Kingdom and Switzerland
March 27, 2025
From
Invivoscribe
Via
Business Wire
EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA
October 08, 2024
From
Invivoscribe
Via
Business Wire
Study Suggests Critical Link Between Residual FLT3-ITD Mutations in Remission and Post-Transplant Outcomes in AML
May 08, 2024
From
Invivoscribe
Via
Business Wire
Invivoscribe Launches Grant Program to Support Novel Applications for Sequence-Based Analyses of the Immune System
June 24, 2021
From
Invivoscribe
Via
Business Wire
Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their Reference Labs in the US, Europe, and China
June 03, 2021
From
Invivoscribe
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.